Skip to main content
IDWeek 2024 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
Live Streamed
On Demand
On Demand
Back

D6. New diagnostics (formerly L2)

Poster Session: New Diagnostics

(P-2222) Optimization And Performance Assessment Of A Novel Assay In The Diagnosis Of Early Lyme Disease.

Saturday, October 19, 2024
12:15 PM – 1:30 PM US PT
Location: Halls JK

    Presenting Author(s)

  • Fabrizio Bonelli, PhD

    VP, Chief Technology Officer
    Diasorin SpA
    Saluggia, Piemonte, Italy

    • Co-Author(s)

  • AR

    Ashli Rode, MS

    Clinical Affairs Manager
    Diasorin Inc.
    Stillwater, Minnesota, United States

  • CZ

    Claudia Zierold, PhD

    Independent Consultant
    Diasorin SpA
    Lugano, Ticino, Switzerland

  • JH

    Jenny Howard, PhD

    VP, Head of Franchise, Immune Response
    QIAGEN
    Germantown, Maryland, United States

  • NA

    Nadia Allen, PhD

    Associate Director, Head of Assay Development
    QIAGEN
    Germantown, Maryland, United States

  • GG

    Giorgio Ghignoni, MD

    VP, Head of Scientific Affairs
    Diasorin SpA
    Saluggia, Piemonte, Italy